Releases & White Papers
           Newsletters
  Generic Alert
 






























Generic Medication Alert

As part of IPC’s continued effort to promote generic prescribing in all appropriate cases, we would like to offer the following list of newly approved generic medications. The list of new generic approvals comes from the United States Food and Drug Administration (FDA),
http://www.fhttp://www.fda.gov/cder/ogd/approvals/.

The Generic Medication Alert includes drugs that have recently been FDA approved. Drugs listed may not yet be available at a retail and/or mail order pharmacy; it would be prudent to check with the pharmacy provider about when it may be available. Generic drugs must have the same active ingredients as its brand name counterpart and can provide savings to its users. Talk with your doctor or pharmacist and explain that you want the most effective drug for your condition at the best price. Ask your doctor to write prescriptions for generic drugs when possible.


Generic Medications FDA Approval Update

1st Quarter 2012

Approved

Generic Name

Brand Name

Strength

Dose Form

Therapy Class

1/25/2012

Polyethylene Glycol 3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorbate & Ascorbic Acid

Moviprep

3350

Oral Solution

Laxative

2/3/2012

Cisatracurium Besylate

Nimbex

2 mg

Injection

Neuromuscular Therapy Agent

2/3/2012

Tizanidine Hydrochloride

Zanaflex

2 mg

Capsules

Musculoskeletal Therapy Agent

2/8/2012

Doxycycline Hyclate

Doryx

150 mg

Delayed Release Tablets

Tetracycline Antibiotics

2/29/2012

Progesterone

Prometrium

100 mg & 200 mg

Capsules

Progestin

 

Homespan class="style1"> | About Us | Solutions | Success | Contact | News | Legal Notice | Privacy Notice